Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CoHSI2: Female-only Controlled Human Schistosoma Mansoni Infection Model
NCT04269915Completed
- Sponsor
- Leiden University Medical Center
- Start
- Aug 2020
- Primary completion
- Apr 2022
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Leiden University Medical Center. Primary endpoints: Adverse Events at 20 weeks and Number of female cercariae for 100% infection at 8 weeks. Started Aug 2020; status: completed.
Beyond the preview
Go deeper on NCT04269915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04269915.